Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study

BACKGROUND: The recent interferon-free direct-acting antiviral (DAA) regimens have very good safety and efficacy profiles and are highly recommended for kidney transplant (KT) recipients with chronic hepatitis C (CHC). METHODS: All KT recipients with CHC followed at our hospital and who received the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Gastroenterol
Main Authors: Darema, Maria, Cholongitas, Evangelos, Filiopoulos, Vassilis, Marinaki, Smaragdi, Pavlopoulou, Ioanna D., Tsoubou, Ioanna, Boletis, John N., Papatheodoridis, George V.
Formato: Artigo
Idioma:Inglês
Publicado em: Hellenic Society of Gastroenterology 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196623/
https://ncbi.nlm.nih.gov/pubmed/32382232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2020.0481
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados